Czech Republic

Capital Prague

Area 78,866 km²

Population 10,660,000

Urbanization rate 73%

Being first among the former Comecon countries to achieve the status of a develped country, Czech Republic is a region where pharmaceutical and biotech companies bring in their most challenging projects.

Central Bohemian Region including the Prague — 2.3 millions
Brno — 0.4 millions
Ostrava — 0.3 millions
Plzen — 0.2 millions
Liberec — 0.1 millions

Experienced Investigators, reduced travel costs and state-of-the-art medical facilities contribute to the Czech Republic being traditionally rated high and known as a place where clinical drug development is safe, fast and cost-effective..

Capital	Prague
Area	78,866 km²
Population	10,660,000
Urbanization rate	73%